Researchers identify protein IL-35 as potential diabetes treatment EP News Bureau Nov 7, 2024 New findings reveal IL-35’s role in immune protection and potential therapeutic pathway for type 1 and autoimmune diabetes
Ozempic linked with lower dementia risk, nicotine use, British study finds Reuters Jul 15, 2024 The study, published in the Lancet's eClinicalMedicine journal, explored more than 100 million medical records of the U.S.…
Eli Lilly’s Mounjaro to become leading GLP-1 therapy for type 2 diabetes in NHS in UK: GlobalData EP News Bureau Sep 21, 2023 The National Institute for Health and Care Excellence (NICE) provided guidance in August 2023 explaining that where triple therapy…
Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India EP News Bureau Feb 6, 2023 It offers a number of advantages including a higher safety profile, higher effectiveness in lower dosage, lower risk of…
USFDA issues CRL for proposed biosimilar Insulin-R: Biocon PTI Jan 11, 2023 The US Food and Drug Administration (USFDA) issues a Complete Response Letter (CRL) to convey to a company that its initial review…
With oral Semaglutide, HCPs can provide robust HbA1c control to their type-II diabetes patients EP News Bureau Dec 2, 2022 Vikrant Shrotriya, MD and CVP, Novo Nordisk India, talks to Express Pharma about the potential and opportunities that the Indian…
Zydus receives final approval from US FDA for Dapagliflozin tablets EP News Bureau Feb 24, 2022 Dapagliflozin is used with a proper diet and an exercise programme to control high blood sugar in people with type-II diabetes